Sanofi (SNY) Other Accumulated Expenses (2009 - 2021)

Sanofi (SNY) has 13 years of Other Accumulated Expenses data on file, last reported at $220.4 million in Q4 2021.

• Quarterly Other Accumulated Expenses rose 4.87% year-over-year to $220.4 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $220.4 million (up 4.87% YoY) and the FY2021 annual result came in at $228.0 million, up 13.29% from the prior year.
• Other Accumulated Expenses grew to $220.4 million in Q4 2021 per SNY's latest filing, from $210.2 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $10.8 billion in Q4 2017, with the low at $161.3 million in Q4 2019.
• Average Other Accumulated Expenses over 5 years is $4.6 billion, with a median of $220.4 million recorded in 2021.
• Year-over-year, Other Accumulated Expenses jumped 1984.99% in 2017 and plunged 98.13% in 2018.
• Sanofi's Other Accumulated Expenses stood at $10.8 billion in 2017, then slumped by 98.24% to $191.0 million in 2018, then slipped by 15.54% to $161.3 million in 2019, then surged by 30.34% to $210.2 million in 2020, then gained by 4.87% to $220.4 million in 2021.
• Business Quant data shows SNY's Other Accumulated Expenses at $220.4 million in Q4 2021, $210.2 million in Q4 2020, and $161.3 million in Q4 2019.